Teva Pharmaceutical Industries Return on Assets:
3.50% for March 31, 2013Teva Pharmaceutical Industries Historical Return on Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 3.50% |
| Dec. 31, 2012 | 3.93% |
| Sept. 30, 2012 | 4.47% |
| June 30, 2012 | 6.81% |
| March 31, 2012 | 6.46% |
| Dec. 31, 2011 | 6.60% |
| Sept. 30, 2011 | 7.64% |
| June 30, 2011 | 8.23% |
| March 31, 2011 | 9.10% |
| Dec. 31, 2010 | 9.27% |
| Sept. 30, 2010 | 8.41% |
| June 30, 2010 | 7.55% |
| March 31, 2010 | 6.85% |
| Dec. 31, 2009 | 6.10% |
| Sept. 30, 2009 | 3.00% |
| June 30, 2009 | 3.12% |
| March 31, 2009 | 3.36% |
| Dec. 31, 2008 | 2.42% |
| Sept. 30, 2008 | 7.85% |
| June 30, 2008 | 7.59% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Return on Assets
Return on Assets (ROA) shows the rate of return (after tax) being earned on all of the firm's assets regardless of financing structure (debt vs. equity). It is a measure of how efficiently the company is using all stakeholders' assets to earn returns.
Because ROA can differ significantly across firms, ROA is often used to compare a company over time or against companies that have similar financing structures.
Learn More
TEVA Return on Assets Benchmarks
| Companies | |
|---|---|
| Alexza Pharmaceuticals | -58.58% |
| Mylan | 5.24% |
| Akorn | 12.40% |
TEVA Return on Assets Rankings
| Overall |
75th percentile 1974 of 8002 |
| Sector |
72nd percentile 179 of 650 in Healthcare |
| Industry |
70th percentile 19 of 65 in Drug Manufacturers - Specialty & Generic |
TEVA Return on Assets Range, Past 5 Years
| Minimum | 2.42% | Dec 2008 |
| Maximum | 9.27% | Dec 2010 |
| Average | 6.11% |
